Quarterly Transactions Made in Intellia Therapeutics, Inc. (NTLA)
This table provides information about the institutional ownership of Intellia Therapeutics, Inc. (NTLA). The information is specifically focused on institutions that hold shares of Intellia Therapeutics, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 5,491,422 | 4,474,862 | 9,966,284 | 6,057,123 | 836,282 | 6,893,405 | 3,072,879 | |
Q4 2021 | 5,535,050 | 778,150 | 6,313,200 | 2,842,473 | 877,606 | 3,720,079 | 2,593,121 | |
Q1 2022 | 6,301,646 | 1,598,168 | 7,899,814 | 5,633,219 | 2,274,015 | 7,907,234 | -7,420 | |
Q2 2022 | 7,253,489 | 1,023,256 | 8,276,745 | 3,803,076 | 1,364,900 | 5,167,976 | 3,108,769 | |
Q3 2022 | 3,853,345 | 2,855,626 | 6,708,971 | 4,587,948 | 11,174 | 4,599,122 | 2,109,849 | |
Q4 2022 | 12,302,111 | 2,187,216 | 14,489,327 | 2,653,307 | 38,308 | 2,691,615 | 11,797,712 | |
Q1 2023 | 7,329,876 | 2,465,958 | 9,795,834 | 4,516,588 | 0 | 4,516,588 | 5,279,246 | |
Q2 2023 | 5,144,664 | 1,455,011 | 6,599,675 | 3,875,191 | 606,398 | 4,481,589 | 2,118,086 | |
Q3 2023 | 5,517,831 | 2,235,479 | 7,753,310 | 3,440,500 | 662,460 | 4,102,960 | 3,650,350 | |
Q4 2023 | 7,697,820 | 5,575,519 | 13,273,339 | 2,995,555 | 0 | 2,995,555 | 10,277,784 | |
Q1 2024 | 9,293,253 | 5,551,094 | 14,844,347 | 3,944,864 | 0 | 3,944,864 | 10,899,483 | |
Q2 2024 | 6,384,063 | 1,696,747 | 8,080,810 | 7,284,836 | 0 | 7,284,836 | 795,974 | |
Q3 2024 | 7,300,463 | 2,522,387 | 9,822,850 | 3,195,674 | 0 | 3,195,674 | 6,627,176 |